Early research (Phase 1)Ended earlyNCT03145909
What this trial is testing
A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)
Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 19